This most current twist while in the Lykos Therapeutics saga threatens A significant overhaul of the organization’s technique and route, with Musk ally and billionaire investor Antonio Gracias showing to need to get the corporate back again toward its nonprofit drug development roots and a far more Doblinite philosophy.Wonderful but not to the fa